Concourse Financial Group Securities, Inc. Pro Mis Neurosciences Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

13 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$0.47 - $0.75 $0 - $0
Q1 2025 May 14, 2025	BUY	$0.64 - $1.12 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$0.88 - $1.35 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$1.2 - $2.27 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.5 - $2.49 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.28 - $2.81 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.97 - $2.0 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.52 - $6.19 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.52 - $6.19 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.7 - $8.14 $0 - $0
Q1 2023 May 15, 2023	BUY	$4.06 - $5.71 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$4.33 - $6.29 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.99 - $9.25 $0 - $0

Others Institutions Holding PMN

# of Institutions

Shares Held

8.47M

Call Options Held

Put Options Held

Great Point Partners LLC Greenwich, CT

2.65M
Shares

$1.01 Million
1.05% of portfolio
Armistice Capital, LLC New York, NY

2.14M
Shares

$812,400
0.02% of portfolio
Sphera Funds Management Ltd. Tel Aviv, L3

1.9M
Shares

$721,732
0.25% of portfolio
Ally Bridge Group (Ny) LLC New York, NY

1.33M
Shares

$507,082
0.92% of portfolio
Allostery Investments LP Stamford, CT

156K
Shares

$59,173
0.97% of portfolio

View Full List

About ProMIS Neurosciences Inc.

Ticker PMN
Exchange OTC
Description
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...

More about PMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account